WebImmune-mediated Examples Inflammatory Bowel Disease, Atopic Dermatitis, Rheumatoid Arthritis, Asthma Immuno-oncology Examples Non-small Cell Lung Cancer, Renal Cell Carcinoma, Melanoma Fibrosis Examples Non-alcoholic steatohepatitis, Systemic Sclerosis, Idiopathic Pulmonary Fibrosis One universe linking mechanisms across diseases, … WebApr 19, 2024 · In the future, the marriage of “deep phenotyping” approaches that companies like CytoReason’s are taking along with mining of real-world evidence from electronic medical records (EMRs) could dramatically reduce the need to conduct massive clinical trials to prove the safety and efficacy of novel drugs. The clinical trials would still be ...
CytoReason - Crunchbase Company Profile & Funding
WebIn a recent example, the CytoReason collaboration helped scientists understand how to best apply an experimental compound that interferes with a CCR6, a protein that is elevated in certain autoimmune diseases. By examining data on the ligand (a molecule that binds to a specific receptor, delivering a signal), its receptor, and the cells that ... WebJan 23, 2024 · CytoReason is a leading technology company developing computational disease models. The company collects proprietary data from pharmaceutical companies and uses it to simulate human diseases ... philosophy\u0027s 3w
CytoReason Announces Collaboration with Ferring to …
WebSep 20, 2024 · Under the terms of the agreement, Pfizer will make a $20M equity investment, have options to license CytoReason’s platform and disease models, and … WebSep 20, 2024 · CytoReason has established itself as a global leader in computational modeling of human diseases thanks to its unique ability to combine computational … WebSep 21, 2024 · In-building usage economy platform developer TULU has topped up its Series A funding round with $5 million. This comes four months after the startup closed … philosophy\\u0027s 3v